A Phase 2 study of perifosine in advanced or metastatic breast cancer
A Phase 2 study of perifosine in advanced or metastatic breast cancer
About this item
Full title
Author / Creator
Publisher
Boston: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
Boston: Springer US
Subjects
More information
Scope and Contents
Contents
Background
First- and second-line chemotherapy with anthracyclines and taxanes in metastatic breast cancer yield a modest improvement in survival with potentially significant toxicity. Subsequent lines of chemotherapy yield response rates of 20–25%, with an unknown impact on survival. Perifosine, an oral alkylphospholipid structurally related to...
Alternative Titles
Full title
A Phase 2 study of perifosine in advanced or metastatic breast cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_212466433
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_212466433
Other Identifiers
ISSN
0167-6806
E-ISSN
1573-7217
DOI
10.1007/s10549-007-9584-x
